BACKGROUND: When anticoagulation is contraindicated or ineffective, optional vena cava filters can be used to prevent pulmonary embolism. These devices can be removed within a defined period of time or can remain in the vena cava permanently. METHODS: The status of optional vena cava filters was studied by a review of the relevant literature found in a selective Medline search from 2000 to 2008, including a Cochrane review and published guidelines. RESULTS: Optional vena cava filter can be removed up to 20 weeks or even longer after insertion (depending on the filter model) in a small interventional radiological procedure if therapeutic anticoagulation has been achieved or the patient is no longer at risk for venous thromboembolism. Current...
interruption has become a widely used procedure in patients with or at risk for venous thromboemboli...
WOS: 000269838400018PubMed ID: 19449061We aimed to evaluate the efficacy and safety of the OptEase a...
inferior vena cava filters (IVCF) are widely used to prevent thromboembolic events in patients not s...
International audienceFilter or without filter? If yes, which one should be chosen? These two questi...
Removable vena caval devices look attractive in order to prevent pulmonary embolism (PE) in high ris...
Venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism (PE), is a major...
BACKGROUND: Nonpermanent caval filters are placed in critical thromboembolic situations in which an...
Venous thromboembolic disease is associated with significant morbidity and mortality. Anticoagulatio...
Abstract Pulmonary thromboembolism constitutes the third cause of death after cardiovascular accide...
PURPOSE: We describe the results of a preliminary prospective study using different recently develop...
Background. The purpose of the present is to assess the effectiveness of pulmonary embolism preventi...
International audienceDespite numerous publications, there is still only one randomised clinical tri...
Background and Objectives : Interruption of the Inferior Vena Cava (IVC) is recommended in certain c...
PURPOSE: To compare the clinical safety and efficiency of two optional inferior vena cava (IVC) filt...
Objective: To report the mid-term results of 63 patients who received a new commercially-available r...
interruption has become a widely used procedure in patients with or at risk for venous thromboemboli...
WOS: 000269838400018PubMed ID: 19449061We aimed to evaluate the efficacy and safety of the OptEase a...
inferior vena cava filters (IVCF) are widely used to prevent thromboembolic events in patients not s...
International audienceFilter or without filter? If yes, which one should be chosen? These two questi...
Removable vena caval devices look attractive in order to prevent pulmonary embolism (PE) in high ris...
Venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism (PE), is a major...
BACKGROUND: Nonpermanent caval filters are placed in critical thromboembolic situations in which an...
Venous thromboembolic disease is associated with significant morbidity and mortality. Anticoagulatio...
Abstract Pulmonary thromboembolism constitutes the third cause of death after cardiovascular accide...
PURPOSE: We describe the results of a preliminary prospective study using different recently develop...
Background. The purpose of the present is to assess the effectiveness of pulmonary embolism preventi...
International audienceDespite numerous publications, there is still only one randomised clinical tri...
Background and Objectives : Interruption of the Inferior Vena Cava (IVC) is recommended in certain c...
PURPOSE: To compare the clinical safety and efficiency of two optional inferior vena cava (IVC) filt...
Objective: To report the mid-term results of 63 patients who received a new commercially-available r...
interruption has become a widely used procedure in patients with or at risk for venous thromboemboli...
WOS: 000269838400018PubMed ID: 19449061We aimed to evaluate the efficacy and safety of the OptEase a...
inferior vena cava filters (IVCF) are widely used to prevent thromboembolic events in patients not s...